Characterizing the proteome composition of organelles and subcellular regions of living cells can facilitate the understanding of cellular organization as well as protein interactome networks. Proximity labeling-based methods coupled with mass spectrometry (MS) offer a high-throughput approach for systematic analysis of spatially restricted proteomes. Proximity labeling utilizes enzymes that generate reactive radicals to covalently tag neighboring proteins with biotin. The biotinylated endogenous proteins can then be isolated for further analysis by MS. To analyze protein-protein interactions or identify components that localize to discrete subcellular compartments, spatial expression is achieved by fusing the enzyme to specific proteins or signal peptides that target to particular subcellular regions. Although these technologies have only been introduced recently, they have already provided deep insights into a wide range of biological processes. Here, we describe and compare current methods of proximity labeling as well as their applications. As each method has its own unique features, the goal of this review is to describe how different proximity labeling methods can be used to answer different biological questions.
INTRODUCTION
S pecialized biological processes occur in different organelles and subcellular regions. In addition, protein functions correlate with their subcellular localizations and interactions. Understanding how cellular structures underlie specialized functions requires the comprehensive identification of proteins within spatially defined cellular domains. Furthermore, identification of interacting proteins is key to elucidating the mechanisms underlying complex cellular processes.
Mass spectrometry (MS) techniques have been used to systematically characterize the proteome of isolated organelles and protein interactors purified by affinity pull-down or following crosslinking. However, these approaches are limited by available purification methods, as it is not possible in many cases to obtain intact organelles of high purity. Moreover, even when purification is possible, contamination that results in false-positive identification is common. For example, false positives may be introduced by cellular disruption, as two proteins that normally localize in different subcellular regions may artificially interact when membranes are disrupted. In addition, false negatives often occur due to loss of components caused by disruption of isolated organelles or protein complexes. Additionally, a variety of discreet cellular regions cannot be purified by centrifugation, such as specialized endoplasmic reticulum (ER)-plasma membrane (PM) junctions that are critical for lipid metabolism and Ca 2+ signaling. [1] [2] [3] [4] Similarly, transient or weak interactions may be lost during purification of a protein interactome due to stringent washes.
Recently, proximity-dependent biotin labeling methods have been developed and utilized for mapping compartmental proteome and protein interactomes. In this review, we compare proximity labeling techniques that utilize different enzymes and describe how they are used to address limitations of traditional methods.
OVERVIEW OF ENZYME-CATALYZED PROXIMITY LABELING FOR PROTEOMIC PROFILING
In general, proximity labeling relies on enzymes that convert a substrate into a reactive radical that covalently tags neighboring proteins with biotin. We will discuss three major enzymes utilized for proximity labeling: proximity-dependent biotin identification (BioID), horseradish peroxidase (HRP), and engineered ascorbate peroxidase (APEX).
To achieve spatially restricted labeling, the enzymes are usually fused with a targeting signal peptide or a protein of interest. After performing proximity labeling in living cells, cells are then lysed and biotinylated endogenous proteins are isolated using streptavidin beads. Small peptides from enriched proteins are generated by trypsin digestion and subsequently ionized for MS analysis. The massto-charge (m/z) ratio of each peptide is then used to identify the peptide sequence, usually through computational comparison against an established database ( Figure 1 ).
To distinguish potential candidates from background, proteins with the highest abundance are usually chosen for further study as a semi-quantitative approach even though low-abundance candidates may potentially be biologically relevant. Alternatively, to generate a high-confidence and comprehensive list of candidates from MS data, proximity labeling has been coupled with quantitative MS. Quantitative MS can be achieved using metabolic labeling such as stable isotope labeling by amino acid in cell culture (SILAC). 5 Cells or organisms are grown with supplement of arginine and lysine residues containing stable 13C and/or 15N to synthesize proteins with altered mass. In LC-MS, each trypsin-digested peptide contains altered amino acids that induce a small shift in the m/z ratio, thus allowing the relative quantification of peptides from different samples. Alternatively, quantitative MS can be done with in vitro chemical labeling, such as isobaric tags for relative and absolute quantification (iTRAQ) 6 and tandem mass tags (TMT), 7 whereby peptides from different samples are modified with chemical tags that can alter the m/z ratio to be detected by MS. Importantly, with proximity labeling, cells remain intact when the proteome or interactome is labeled. Thus, the potential for false-positive identifications is minimized, as artificial interactions caused by disruption of cells and contaminants during purification steps no longer affect the results. Moreover, proximity labeling can be applied to bypass organelle purification steps, offering an alternative approach
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Expressing spatially-restricted proximity labeling enzyme Enzyme SP Enzyme activation + substrates Cell lysis FIGURE 1 | Proximity labeling for proteomic profiling. To achieve regional protein labeling, the enzymes are usually fused with a targeting signal peptide or a spatially restricted protein (SP). The enzymes can also be fused with any protein of interest for protein interactome studies. After performing proximity labeling in living cells, the cells are lysed and the biotinylated endogenous proteins are isolated using steptavidin beads. Small peptides of enriched proteins are generated by trypsin digestion and subsequently ionized for mass spectrometry analysis. The mass-to-charge (m/z) ratio of each peptide is then used to identify peptide sequence usually through computational comparison against established databases.
for systematic proteomic characterization in live cells. As proximity labeling is an emerging method that enables proteomic profiling of organelles and subcellular domains as well as protein interactomes, this review aims to provide an overview of the different methods to aid planning and execution of future experiments.
BioID-BASED PROXIMITY LABELING
BioID-based proximity labeling employs a mutant form of the biotin ligase BirA from E. coli. [8] [9] [10] The biotin ligase BirA is a conserved enzyme that mediates the attachment of biotin to target proteins. 11 In the presence of ATP, BirA biotinylates proteins by catalyzing the conversion of biotin to reactive biotinoyl-5 0 -AMP, which specifically tags a lysine residue of a subunit of the acetyl-CoA carboxylase. 8, 12 Wild-type BirA has a high affinity to biotinol-5 0 -AMP and keeps it in the active site until the acetylCoA carboxylase, or a short acceptor peptide, becomes available. 13 As BirA has a high specificity for its target sequence, it has been used to study specific protein-protein interactions 14 : BirA is fused to a bait protein and biotin acceptor peptide (BAP) is fused to a prey protein. If the interaction occurs, the prey will be close enough to the bait to become biotinylated.
To achieve promiscuous labeling, the active site of BirA has been mutated, enabling random biotinylation of vicinity proteins without BAP. 8, 9 This method is named BioID and the mutated form of BirA for proximity labeling is called BioID or BirA* to be distinguished from the wild-type and other mutant forms of BirA 10 ( Figure 2 ). When the active site of BirA is mutated (R118G), its affinity to biotin-5 0 -AMP is greatly reduced. The highly reactive biotinoyl-5 0 -AMP is released from the active site of BioID and nonspecifically reacts with nearby proteins. Therefore, BioID can covalently tag nearby endogenous proteins on lysine residues. Although the labeling radius of BioID may vary depending on the local environmental, the labeling radius of BioID is estimated to be around 10 nm using the structure of the nuclear pore complex as a 'molecular ruler.' 15 BioID has been used to map local interactomes and identify transient protein interactions, and thus provides a better understanding of cellular structures as well as interactions occurring during signal transduction. Recently, a new version of BioID, BioID2, has been generated with an R40G mutation in the reactive site of BirA from Aquifex aeolicus to allow promiscuous labeling. 16 BioID2 lacks the DNA binding domain at the N-terminus and is thus smaller (233 a.a.) than the original BioID derived from E. coli (321 a.a.). BioID2 performs similar labeling chemistry as BioID but shows a higher activity and requires less biotin. As the application and impact of BioID have been extensively reviewed, 17, 18 we focus here on introducing the more recently developed APEX-mediated approach and on the comparisons between labeling methods.
HRP-BASED PROXIMITY LABELING
HRP is a peroxidase that, when activated by H 2 O 2 , is able to convert a substrate into a highly reactive radical that covalently tags neighboring proteins on electron-rich amino acids. 19 HRP is inactive in a reducing environment, such as the cytosol, because the structure of HRP, which is maintained with four disulfide bonds and two Ca 2+ ion-binding sites, is disrupted in reducing conditions. 20 This has limited its use for determining intracellular interactomes, and motivated the development of APEX. Nevertheless, HRP is active in oxidizing environments, such as the lumen of the ER or the Golgi and the extracellular region. Thus, HRP has been used for proteomic mapping on the surface of living cells. In addition, HRP can also be used as an electron microscopy (EM) tag. 21 With H 2 O 2 , HRP can catalyze the polymerization of 3,3'-diaminobenzidine (DAB), which precipitates and creates an EM contrast after OsO 4 fixation.
Although HRP can catalyze a variety of substrates, for proximity labeling two in particular have been used: (1) the enzyme-mediated activation of radical source (EMARS) method uses fluorescein arylazide or biotin arylazide. [22] [23] [24] [25] [26] [27] [28] [29] [30] Fluorescein arylazide reduces the cytosolic background generated by biotin-aryl azide, 23 which is membrane permeable during the EMARS reaction and activated by endogenous enzymes 22, 24 ; and (2) the selective proteomic proximity labeling assay using tyramide (SPPLAT) method using biotin-tyramide, which is also known as biotin-phenol. 19, 31 HRP has been used extensively for other applications, such as ELISA and immunochemistry. 32 Furthermore, antibody-HRP conjugates have been generated that can also be used for proximity labeling. However, this application is limited by the affinity of the antibody. Nevertheless, antibody-HRP conjugates have been successfully used to identify cell surface molecules such as the composition of the Bcell receptor cluster, as well as proteins that interact with Thy1, β1 integrin, CD20, and PrPC. 19, [22] [23] [24] [25] [26] [27] [28] [29] [30] 
APEX-BASED PROXIMITY LABELING
APEX, an engineered ascorbate peroxidase derived from plants, uses the same labeling chemistry and rapid kinetics as HRP to convert a substrate into a radical in the presence of H 2 O 2.
33, 34 The key advantage of APEX over HRP, however, is that it remains active in the reducing environment of the cellular cytosol. Upon activation by H 2 O 2 , APEX catalyzes the conversion of its substrate biotin-phenol into shortlived (<1 ms) and highly reactive radicals, which can covalently attach to electron-rich amino acids such as tyrosine in nearby endogenous proteins. 34, 35 The labeling reaction can be stopped by the removal of H 2 O 2 and the addition of quenching buffer, and the resulting biotinylated proteins can be subsequently isolated using streptavidin beads and further analyzed by MS. In addition, APEX can catalyze the polymerization and precipitation of DAB creating a contrast after OsO 4 fixation, 33 which can then be used for EM to visualize the structures where APEX is expressed.
Yeast display selection has been performed to screen for mutations that increase APEX activity. 36 An improved version of APEX, called APEX2, has one additional mutation (A134P) and catalyzes the same chemistry as APEX but with higher activity and sensitivity for promiscuous labeling and EM.
APEX-mediated proximity labeling was first introduced by Rhee and colleagues to circumvent the FIGURE 2 | Proximity labeling methods. BioID, a mutant form of the biotin ligase BirA, can convert biotin into radicals that can covalently tag neighboring proteins on lysine residues. HRP and APEX are peroxidases that, when activated by H 2 O 2 , are able to turn biotin-phenol substrates into highly reactive radicals that covalently tag neighboring proteins on electron-rich amino acids. In addition, fluorescein-aryl azide or biotin-aryl azide have been used for HRP-mediated proximity labeling (not shown in the figure) . HRP is inactive in a reducing environment, such as the cytosol, but functions extracellularly. APEX, engineered ascorbate peroxidase; BioID, proximity-dependent biotin identification; HRP, horseradish peroxidase; SP, spatially restricted protein.
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wires.wiley.com/devbio limitations of traditional mitochondrial purification and to achieve spatial and temporal specificity of organelle proteome mapping. 34 To examine the ability of APEX in proteomic labeling, a mitochondrial matrix-targeted APEX was used in human embryonic kidney (HEK) cells. Mitochondria are comprised of an outer membrane (OMM) and an inner membrane (IMM). The mitochondrial matrix is the most inner subcompartmental region surrounded by the IMM. The region located between the OMM and IMM is called the intermembrane space (IMS). To induce APEX-mediated proximity labeling, cells were preincubated with biotin-phenol followed by 1 min H 2 O 2 treatment for APEX activation. To eliminate the background from endogenous biotinylated proteins and nonspecific candidates caused by the labeling procedure, a two-state SILAC labeling coupled with MS was used for relative quantification. Prior to APEX labeling, one group of cells expressing the mitochondrial matrix localized mito-APEX was cultured with heavy media (heavy arginine and lysine), and another group of cells without APEX, used as a negative control, was cultured with light medium (light arginine and lysine). After cell lysis, biotinylated endogenous proteins were enriched using streptavidin beads and then processed for MS analysis. Consequently, 495 proteins were identified as putative components of the mitochondrial matrix. Ninety-four percent of these proteins had prior mitochondrial annotation. This not only demonstrates that APEX-mediated proteomic mapping provides high specificity but also implies that the other 6% (31 proteins) are novel mitochondrial proteins. In addition, mito-APEX labeling provided a high coverage (85%) of known functional mitochondrial components.
The power of quantitative MS and the importance of appropriate controls are well illustrated by the study of mitochondrial IMS. 35 As the outer mitochondrial membrane has pores that permit passive diffusion, highly reactive radicals generated by IMS-APEX diffuse within and out of the IMS to biotinylate cytosolic proteins. Simply using cells without APEX as a negative control is not sufficient to filter out the false-positively labeled cytosolic proteins. To solve this problem, an additional cytosolic APEX control, referred to as ratiometric APEX tagging, was used with a three-state SILAC experiment for quantitative MS: cells labeled with IMS-APEX, with cytosolic NES-APEX, or without APEX as a negative control, were cultured with heavy, medium, and light SILAC media. Using the biotinylated ratio among these three samples to define the IMS proteome, mitochondrial specificity was improved (from 40 to 80%) while the coverage of known IMS proteins dropped only very slightly (from 69 to 67%). The drop in coverage may represent false-negative results due to the removal of proteins localized both in the IMS and in the cytosol.
As biotin-phenoxyl radicals are not membranepermeable, 34 APEX is excellent for proteomic profiling of membrane-enclosed subcellular compartments, such as the mitochondrial matrix. Nevertheless, APEX is not limited to analysis of membraneenclosed organelles, and has been used successfully to profile the proteome of nonmembrane enclosed organelles. 37 Using cilia-localized APEX, signaling molecules such as the kinases PKA, AMPK, and LKB1 were identified in primary cilia. Rather than using quantitative MS, enrichment was estimated by comparing spectral counts from the labeled cilia-APEX sample to those from unlabeled cilia-APEX and a labeled control-APEX sample. Moreover, a proteomic profile of dysfunctional cilia was obtained by comparing cilia-APEX-based profiling of wildtype and lft27 mutant cells, and identified abnormal accumulation of factors. In addition to successful use of APEX for organelle profiling, APEX also provides a good tool for identification of protein-protein interactions. For example, APEX2 was fused with the ER-resident Ca 2+ sensor STIM1 to map the proteome of the ER-PM junction in living cells, leading to the identification of the STIM-activating enhancer TMEM110 (STIMATE). 38 The APEX-based approach has also been used successfully in vivo. 39 APEX was shown to be active in different Drosophila tissues when expressed in multiple subcellular domains. A mito-APEX construct was used to characterize the mitochondrial matrix proteome in live Drosophila muscle cells. Muscle tissue with or without mito-APEX expression was dissected and labeled with biotin-phenol, and biotinylated proteins were subsequently isolated using streptavidin beads. After on-bead tryptic digestion, peptides from control muscles that do not express APEX and muscles expressing mitochondrial APEX were chemically labeled with 4-plex iTRAQ and simultaneously analyzed by MS. iTRAQ enables comparison between samples of muscle with and without mito-APEX expression, allowing one to distinguish between proteins specifically biotinylated by APEX and endogenously biotinylated proteins. Use of an APEX-based method for mitochondrial matrix mapping in Drosophila achieved an excellent specificity (83% compared with 49-57% for the isolationbased approach) with high coverage.
The APEX2 approach has been further adapted to yeast cells. 40 Additional steps that boost biotinphenol delivery are required to achieve optimal APEX2 labeling in yeast. 40, 41 In addition, an increase in osmolarity has been shown to promote biotinphenol uptake or retention, significantly increasing APEX2 labeling in the fission yeast Schizosaccharomyces pombe. Interestingly, high osmolarity alone is insufficient to achieve proper APEX2 labeling in the budding yeast Saccharomyces cerevisiae. Disruption of cell wall integrity using Zymolyase dramatically improved the labeling efficiency in budding yeast, even though the general composition of the cell wall in these two species of yeast is similar. Using the optimized protocol for APEX2 labeling in yeast, a binding protein of the Golgi-localized protease Rbd2 was identified and shown to function in the ability of Rbd2 to recognize its targets.
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COMPARISON BETWEEN BIOTIN LIGASE-BASED AND PEROXIDASE-BASED APPROACHES
The major differences between biotin ligase-based and peroxidase-based labeling approaches are the substrates, the targeted amino acid(s), the kinetics, and the working conditions (Table 1 ). In addition to differences in proteomic labeling, APEX, like HRP, can be used for EM, thus allowing confirmation of fine subcellular localization. However, the proper expression and localization of BioID can only be verified by other methods like immunostaining and/or Western blotting to rule out the possibility of false positive from mis-localization of the fusion proteins or slow translation of the fusion protein.
Whereas the biotin ligase-based method uses biotin as a substrate, the peroxidase-based approaches use biotin-phenol as the substrate for proteomic analysis. Delivery of the substrate to the region of interest is a critical factor. Biotin is actively imported into mammalian cells and other organisms though distinct mechanisms. 43 Even though biotinphenol can be simply incubated with mammalian cells for cytosolic and mitochondrial protein labeling, a number of studies have shown that biotin-phenol may not effectively penetrate membranes. 19, 31 Moreover, high osmolarity and perturbation of the cell wall are required for efficient delivery of biotinphenol and optimal proximity labeling in yeast. 40 Therefore, optimizing biotin-phenol delivery to a region of interest in a specific cell type may be required to achieve successful protein labeling. In addition, the half-life of BioID generated biotin-5 0 -AMP radicals is on the order of minutes in aqueous solutions, 44 which is longer than that of APEXgenerated biotin-phenoxyl radicals (<1 ms). 34, 35 The shorter half-life of unstable radicals may result in a smaller labeling radius, which is also determined by other factors, such as local intracellular environments. Unfortunately, the labeling radius of BioID and APEX has been estimated by different methods and in different cellular regions.
BioID labels lysine residues of nearby proteins whereas APEX and HRP tag electron-rich tyrosine residues. Generally, the estimated amount of lysine present in proteins is higher than that of tyrosine. 45, 46 Thus, when the number of available tyrosine residues is limited, potential target proteins may not be identified using APEX and HRP.
Importantly, BioID shows much slower kinetics than APEX or HRP. The optimal labeling time for APEX (~1 min) is shorter than that for HRP (5-10 min) and much shorter than for BioID (15-24 h ). Although biotin is not toxic, biotinylation of proteins over the long BioID labeling period may perturb protein function or lead to artificial interactions. In addition to the unique chemical attributes of each type of reaction, there is a dramatic difference in the temporal landscape of the proteomes obtained by the two methods. While BioID is useful in capturing entire changes in protein complexes during a longer period of time, APEX is excellent for characterizing rapid dynamic changes in proteomes that can only be achieved with a short labeling window, such as acute responses to drug treatment.
Notably, the activity of BioID or BioID2 is greatly reduced at temperatures below 37 C. 16 For model systems that need to be maintained under 37 C, BioID cannot be easily used. Nevertheless, BioID has been successfully applied to several organisms in addition to mammalian cells, [47] [48] [49] [50] [51] [52] [53] [54] as summarized in Table 1 . However, APEX has been shown to be active in Drosophila cultured cells at 25 C and in yeast cultured at room temperature, in addition to showing good activity in mammalian cells that are cultured at 37
C. This temperature range allows APEX to be broadly suitable for studies in a variety of model organisms.
COMPARISON BETWEEN APEX AND HRP-BASED APPROACHES
In contrast to BioID, both APEX and HRP catalyze the same proximity labeling chemistry. The key parameter that one should consider for their usage is the environment to which the enzyme will be exposed. As mentioned above, HRP is inactive in the cytosol; however, it is functional when it faces outside the cell on the cell surface and has been successfully used to identify membrane proteins. 19, [22] [23] [24] [25] [26] [27] [28] [29] [30] Notably, many previous studies used antibodyconjugated HRP. 19, [22] [23] [24] [26] [27] [28] [29] [30] A key advantage of the HRP-mediated approach is that many antibody-HRP conjugates are currently available. As noted previously, however, the use of antibody-conjugated HRP in proximity labeling is limited by the affinity of the antibody.
Interestingly, a bimolecular complementation version of HRP has recently been reported. 55 This split HRP has been generated to characterize intercellular protein-protein interactions and visualize synapses. The two split HRP fragments were fused with neurexin and neuroligin, which bind to each other across the synaptic cleft. When the split fragments are brought together as a result of the neurexin-neuroligin interaction, they reconstitute a functional form of HRP that allows proximity labeling. This binary system offers another level of control to the HRP system, making it useful for finer spatial restriction. Although split HRP has not yet been used for proteomics, its potential use for proteomic mapping of cell-cell interactions is very promising.
CONCLUSION/PERSPECTIVES
Since the recent introduction of proximity labeling, the method has made significant contributions to the mapping of local interactomes relevant to a wide range of biological processes. By tagging regional proteomes, proximity labeling overcomes issues associated with traditional approaches of organelle purification and allows proteomic analysis of other types of subcellular regions. A disadvantage that all proximity labeling-based methods have in common is that they cannot distinguish direct binding of two proteins from proximity of two adjacent proteins. Thus, these methods serve as discovery methods that require detailed follow-up studies. Nevertheless, as proximity labeling does not require disruption of cells for complex isolation, these methods not only preserve evidence of weak or transient interactions that are not detectable using traditional approaches but also minimizes false discovery by eliminating false positives generated during lysis or disruption. Importantly, as proximity labeling can be performed in living cells, researchers can study protein-protein interactions and proteomic alterations in physiologically relevant conditions. Proximity labeling has been adapted to several model systems, making this technology available to study diverse biological problems in a wide range of organisms.
Notably, while improved second-generation BioID and APEX are now available, further improvements are likely to be made in the near future. In particular, variants of BioID with faster kinetics and higher activity at lower temperatures would be more suitable for a broad range of model organisms. In addition, a split APEX2 that could reconstitute a functional APEX would also find many applications. For mapping specific subcellular regions, such as organelleorganelle interaction sites, split APEX2 may provide a way to further fine-tune spatial restrictions.
Importantly, the ease of applying genetically encoded enzymes will benefit greatly from the powerful genome editing using CRISPR technology, 56, 57 as these enzymes can now be easily fused to any gene of interest via a knock-in approach. In addition, numerous genetic engineering tools already available for organisms such as Drosophila facilitate a wide range of proximity-labeling applications. For example, the existing library of MiMICs, a transposon insertion resource for engineering Drosophila genes, allows for rapid tagging of genes. 58, 59 Altogether, a broad range of proximity-labeling applications that build on existing tools are now possible and likely to provide deep insights into various biological questions.
